Triggering of cardiovascular disease by infection type: The Atherosclerosis Risk in Communities study (ARIC)

Logan T Cowan1, Brian Buck1, Jessica S Schwind1

  • 1Department of Biostatistics, Epidemiology, & Environmental Health Sciences, Georgia Southern University, PO Box 7989, Statesboro, GA 30460, United States of America.

Insights

Acute infections like pneumonia and urinary tract infections significantly increase cardiovascular disease risk, particularly within 14 days. This highlights the need for preventive strategies post-infection.

Area of Science:

  • Infectious Disease Epidemiology
  • Cardiovascular Disease Research
  • Public Health

Background:

  • Acute infections are recognized triggers for cardiovascular disease (CVD).
  • The differential impact of various infection types on CVD risk remains unclear.
  • Understanding these associations is crucial for risk stratification and prevention.

Purpose of the Study:

  • To investigate the association between specific acute infections and the risk of acute coronary heart disease (CHD) and ischemic stroke.
  • To determine if the strength of this association varies across different types of infections.

Main Methods:

  • A case-crossover design was employed using data from the Atherosclerosis Risk in Communities Study (ARIC).
  • Infections including cellulitis, pneumonia, urinary tract infections (UTI), and bloodstream infections were identified using ICD-9 codes from Medicare claims.
  • Conditional logistic regression analyzed the risk of CHD and ischemic stroke events in the 14, 30, 42, and 90 days following infection compared to control periods.

Main Results:

  • Pneumonia, UTI, bloodstream infections, and cellulitis were associated with increased acute CHD risk within 14 days post-infection.
  • Pneumonia (OR=25.53) and UTI (OR=3.32) showed significant associations with acute CHD.
  • Pneumonia (OR=5.59) and UTI (OR=3.16) were also linked to increased ischemic stroke risk within 14 days.

Conclusions:

  • Patients experiencing pneumonia, UTI, or bloodstream infections face a substantially elevated risk of cardiovascular events.
  • The risk elevation ranges from 2.5 to 25.5 fold, particularly in the initial 14 days post-infection.
  • Consideration of preventive therapies during this high-risk period is recommended to mitigate CVD events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
718
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
222
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
542
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
291
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
501
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
221